Terns Pharmaceuticals Stock Market Value
| TERN Stock | USD 39.58 1.79 4.74% |
| Symbol | Terns |
Will Pharmaceuticals sector continue expanding? Could Terns diversify its offerings? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Terns Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Terns Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Terns's accounting equity. The concept of intrinsic value - what Terns Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Terns Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Terns Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Terns Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Terns Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Terns Pharmaceuticals.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Terns Pharmaceuticals on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Terns Pharmaceuticals or generate 0.0% return on investment in Terns Pharmaceuticals over 90 days. Terns Pharmaceuticals is related to or competes with Oric Pharmaceuticals, Precigen, Immatics, Enliven Therapeutics, Amylyx Pharmaceuticals, Nektar Therapeutics, and Relay Therapeutics. Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combin... More
Terns Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Terns Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Terns Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.16 | |||
| Information Ratio | 0.1812 | |||
| Maximum Drawdown | 43.41 | |||
| Value At Risk | (5.58) | |||
| Potential Upside | 8.22 |
Terns Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Terns Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Terns Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Terns Pharmaceuticals historical prices to predict the future Terns Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1596 | |||
| Jensen Alpha | 1.16 | |||
| Total Risk Alpha | 0.8181 | |||
| Sortino Ratio | 0.35 | |||
| Treynor Ratio | (3.67) |
Terns Pharmaceuticals February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1596 | |||
| Market Risk Adjusted Performance | (3.66) | |||
| Mean Deviation | 3.9 | |||
| Semi Deviation | 2.58 | |||
| Downside Deviation | 3.16 | |||
| Coefficient Of Variation | 526.73 | |||
| Standard Deviation | 6.1 | |||
| Variance | 37.24 | |||
| Information Ratio | 0.1812 | |||
| Jensen Alpha | 1.16 | |||
| Total Risk Alpha | 0.8181 | |||
| Sortino Ratio | 0.35 | |||
| Treynor Ratio | (3.67) | |||
| Maximum Drawdown | 43.41 | |||
| Value At Risk | (5.58) | |||
| Potential Upside | 8.22 | |||
| Downside Variance | 9.98 | |||
| Semi Variance | 6.66 | |||
| Expected Short fall | (5.01) | |||
| Skewness | 3.31 | |||
| Kurtosis | 17.66 |
Terns Pharmaceuticals Backtested Returns
Terns Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Terns Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. By inspecting Terns Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.87% is justified by implied risk. Please review Terns Pharmaceuticals' Coefficient Of Variation of 526.73, semi deviation of 2.58, and Risk Adjusted Performance of 0.1596 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Terns Pharmaceuticals holds a performance score of 11. The entity has a beta of -0.31, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Terns Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Terns Pharmaceuticals is likely to outperform the market. Please check Terns Pharmaceuticals' potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Terns Pharmaceuticals' existing price patterns will revert.
Auto-correlation | -0.27 |
Weak reverse predictability
Terns Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Terns Pharmaceuticals time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Terns Pharmaceuticals price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Terns Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 2.99 |
Pair Trading with Terns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Terns Stock
| 0.77 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.59 | HCM | HUTCHMED China | PairCorr |
| 0.56 | IQ70 | 1CM INC | PairCorr |
| 0.53 | NXS | Next Science | PairCorr |
| 0.51 | BSFA | ANI Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Terns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Terns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Terns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Terns Pharmaceuticals to buy it.
The correlation of Terns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Terns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Terns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Terns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Terns Pharmaceuticals Correlation, Terns Pharmaceuticals Volatility and Terns Pharmaceuticals Performance module to complement your research on Terns Pharmaceuticals. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.